Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome
- 1 September 1988
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 85 (3), 289-291
- https://doi.org/10.1016/0002-9343(88)90576-1
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.The Journal of Experimental Medicine, 1988
- Tumors secreting human TNF/cachectin induce cachexia in miceCell, 1987
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987
- Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factorsNature, 1986
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985
- A Macrophage Factor Inhibits Adipocyte Gene Expression: An in Vitro Model of CachexiaScience, 1985
- Identity of tumour necrosis factor and the macrophage-secreted factor cachectinNature, 1985
- Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells.The Journal of Experimental Medicine, 1985
- DIVERSITY OF CLINICAL SPECTRUM OF HTLV-III INFECTIONThe Lancet, 1985
- Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude miceInternational Journal of Cancer, 1984